{"@id":"https://bioecon.ru/technology/aav-retinal-gene-therapy/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://bioecon.ru/technology/aav-retinal-gene-therapy/","json":"https://bioecon.ru/api/v1/technology/aav-retinal-gene-therapy/index.json"},"id":"aav-retinal-gene-therapy","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/minicircle/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/bioviva/","https://bioecon.ru/companies/pbs-biotech/","https://bioecon.ru/companies/anft-association-of-nature-forest-therapy/","https://bioecon.ru/companies/becton-dickinson/"]},"maturity":7,"name":"Ретинальная генотерапия на основе векторов AAV","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Эволюция тропизма капсидов"},{"n":2,"title":"Субретинальная микрокануляция"},{"n":3,"title":"Тканеспецифичные промоторы"},{"n":4,"title":"Электроретинографический контроль"}],"summary":"Инженерия капсидов AAV для субретинальной и интравитреальной доставки генов в фоторецепторы и пигментный эпителий глаза для лечения наследственных дистрофий сетчатки.","url":"/technology/aav-retinal-gene-therapy/","verified":"2026-11-22"}